0001140361-21-008342.txt : 20210312
0001140361-21-008342.hdr.sgml : 20210312
20210312163555
ACCESSION NUMBER: 0001140361-21-008342
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210308
FILED AS OF DATE: 20210312
DATE AS OF CHANGE: 20210312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wrighton-Smith Peter
CENTRAL INDEX KEY: 0001592286
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 21737970
MAIL ADDRESS:
STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC
STREET 2: 94C INNOVATION DRIVE
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
form4.xml
FORM 4
X0306
4
2021-03-08
true
0001586049
Oxford Immunotec Global PLC
OXFD
0001592286
Wrighton-Smith Peter
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
true
true
Chief Executive Officer
Ordinary Shares
2021-03-08
4
D
0
400225
22
D
0
D
Stock Option (Right to Buy)
14.12
2021-03-08
4
D
0
41931
7.88
D
2025-06-19
Ordinary Shares
41931
0
D
Stock Option (Right to Buy)
13.5
2021-03-08
4
D
0
105255
8.5
D
2027-02-24
Ordinary Shares
105255
0
D
Stock Option (Right to Buy)
13.24
2021-03-08
4
D
0
103330
8.76
D
2028-03-15
Ordinary Shares
103330
0
D
Stock Option (Right to Buy)
16.42
2021-03-08
4
D
0
67959
5.58
D
2029-04-01
Ordinary Shares
67959
0
D
Stock Option (Right to Buy)
12.19
2021-03-08
4
D
0
62087
9.81
D
2030-03-11
Ordinary Shares
62087
0
D
Stock Option (Right to Buy)
10.21
2021-03-08
4
D
0
128959
11.79
D
2026-03-04
Ordinary Shares
128959
0
D
Stock Option (Right to Buy)
14.57
2021-03-08
4
D
0
51403
7.43
D
2025-01-16
Ordinary Shares
51403
0
D
Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited (the "Bidco") of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").
In connection with the Scheme, all stock options were transferred to Bidco in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price.
Represents the payment per ordinary share received in exchange for the transfer of each option of $22.00, less the applicable exercise price.
/s/ Matthew T E McLaughlin, as Attorney-in-Fact for Peter Wrighton-Smith
2021-03-12